Alessia Pasquini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alessia Pasquini has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Benedicto Crespo-Facorro
Mental Health Service, Virgen del Rocío University Hospital; Seville, Spain. Instituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC/University of Seville / CIBERSAM, ISCIII, Seville, Spain
1 shared publication- Chloé Gomez
Department of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, Seville, Spain
1 shared publication - Claudio Alemán-Morillo
Department of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, Seville, Spain
1 shared publication - Javier Vázquez-Bourgon
Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain
1 shared publication - John Suckling
Department of Psychiatry, University of Cambridge
1 shared publication - Lena Dorfschmidt
School of Biomedical Engineering & Imaging Sciences, King’s College London, UK
1 shared publication
Latest Publications
- Open Access
- 15 July 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Early deviations from normative brain morphology and cortical microstructure in schizophrenia spectrum disorders
In schizophrenia spectrum disorders (SSD), structural alterations of the gray matter (GM) and white matter (WM) have been widely described. However, the complex interplay between early disease-related changes and ongoing brain maturation challenges our ability to identify early biomarkers. In this study, we investigated structural abnormalities and their association with symptoms in a drug-naïve or minimally medicated sample comprising 113 patients with SSD and 112 neurotypical controls. Specifically, we derived centile scores using normative modelling from cortical thickness (CT), and subcortical volumes derived from structural MRI images, and diffusion tensor imaging-derived (DTI) WM tract fractional anisotropy (FA). In addition, we derived raw cortical mean diffusivity (cMD) metrics from DTI. Compared to controls, SSD participants showed reduced CT centiles, ventricular enlargement, and subcortical centile reductions in the hippocampus, thalamus, amygdala, and nucleus accumbens. SSD was also associated with widespread increases in cMD. We also explored associations among these structural markers, identifying significant relationships between CT centiles and raw cMD, as well as between subcortical centiles and FA tract-based centiles. No interaction with SSD diagnosis was found. Furthermore, positive symptoms correlated negatively with CT and FA tract-based centiles, and showed widespread positive associations with raw cMD, whereas negative symptoms showed no associations. These findings underscore multimodal brain abnormalities that originate early in the course of SSD and their distinct associations with symptoms. Our results support the potential of both normative modelling and diffusion imaging markers to identify individualized early brain changes in SSD Among these, cMD emerges as a potential marker of SSD-related microstructural alterations.
- 15 July 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessEarly deviations from normative brain morphology and cortical microstructure in schizophrenia spectrum disorders
In schizophrenia spectrum disorders (SSD), structural alterations of the gray matter (GM) and white matter (WM) have been widely described. However, the complex interplay between early disease-related changes and ongoing brain maturation challenges our ability to identify early biomarkers. In this study, we investigated structural abnormalities and their association with symptoms in a drug-naïve or minimally medicated sample comprising 113 patients with SSD and 112 neurotypical controls. Specifically, we derived centile scores using normative modelling from cortical thickness (CT), and subcortical volumes derived from structural MRI images, and diffusion tensor imaging-derived (DTI) WM tract fractional anisotropy (FA). In addition, we derived raw cortical mean diffusivity (cMD) metrics from DTI. Compared to controls, SSD participants showed reduced CT centiles, ventricular enlargement, and subcortical centile reductions in the hippocampus, thalamus, amygdala, and nucleus accumbens. SSD was also associated with widespread increases in cMD. We also explored associations among these structural markers, identifying significant relationships between CT centiles and raw cMD, as well as between subcortical centiles and FA tract-based centiles. No interaction with SSD diagnosis was found. Furthermore, positive symptoms correlated negatively with CT and FA tract-based centiles, and showed widespread positive associations with raw cMD, whereas negative symptoms showed no associations. These findings underscore multimodal brain abnormalities that originate early in the course of SSD and their distinct associations with symptoms. Our results support the potential of both normative modelling and diffusion imaging markers to identify individualized early brain changes in SSD Among these, cMD emerges as a potential marker of SSD-related microstructural alterations.